Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators
Rachel Lampert, MD, FACC*,*,
Craig A. McPherson, MD, FACC*,
Jude F. Clancy, MD*,
Teresa L. Caulin-Glaser, MD, FACC ,
Lynda E. Rosenfeld, MD, FACC* and
William P. Batsford, MD*
* Yale University School of Medicine, Department of Internal Medicine, New Haven, Connecticut, USA
McConnell Heart Health Center, Riverside Methodist Hospital, Columbus, Ohio, USA

View larger version (34K):
[in a new window]
|
Figure 1 Incidence of any ventricular tachycardia (VT)/ventricular fibrillation (VF) after implantable cardioverter-defibrillator (ICD) implantation in men versus women, for the entire population and by indication for implantable cardioverter-defibrillator. MADIT = Multicenter Automatic Defibrillator Implantation Trial; MUSTT = Multicenter UnSustained Tachycardia Trial.
|
|

View larger version (18K):
[in a new window]
|
Figure 2 Distribution of ventricular arrhythmia frequency by gender. Modified box-plot: thick lines = median, center lines = 75th percentile, and top lines = 90th percentile; whiskers = maximum event frequencies. Event frequency is expressed in percentiles because of skewness of distribution.
|
|

View larger version (27K):
[in a new window]
|
Figure 3 Kaplan-Meier survival curve comparing total mortality after implantable cardioverter-defibrillator implantation between men and women.
|
|
|